pBLO1811_Cas9_noNLS_human Citations (1)
Originally described in: Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch.Oakes BL, Nadler DC, Flamholz A, Fellmann C, Staahl BT, Doudna JA, Savage DF Nat Biotechnol. 2016 May 2. doi: 10.1038/nbt.3528. PubMed Journal
Articles Citing pBLO1811_Cas9_noNLS_human
| Articles |
|---|
| Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy. Salimi-Jeda A, Esghaei M, Hossein Keyvani, Bokharaei-Salim F, Teimoori A, Abdoli A. Heliyon. 2022 Aug 31;8(9):e10483. doi: 10.1016/j.heliyon.2022.e10483. eCollection 2022 Sep. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.